BRUNO SOUZA

Dr. BRUNO SOUZA

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2016 in Scientific Reports
Verified
Journal Article
Open access
BSBRUNO SOUZA
BRUNO SOUZA
GSGabriela L. A. Sampaio
Gabriela L. A. Sampaio
CPCiro S. Pereira
Ciro S. Pereira
GCGubio S. Campos
Gubio S. Campos
SSSílvia I. Sardi
Sílvia I. Sardi
Milena SoaresMilena Soares
Milena Soares
Zika virus (ZIKV) infection has been associated with severe complications both in the developing and adult nervous system. To investigate the deleterious effects of ZIKV infection, we used human neural progenitor cells (NPC), derived from induced pluripotent stem cells (iPSC). We found that NPC are highly susceptible to ZIKV and the infection results in cell death. ZIKV infection led to a marked reduction in cell proliferation, ultrastructural alterations and induction of autophagy. Induction of apoptosis of Sox2+ cells was demonstrated by activation of caspases 3/7, 8 and 9, and by ultrastructural and flow cytometry analyses. ZIKV-induced death of Sox2+ cells was prevented by incubation with the pan-caspase inhibitor, Z-VAD-FMK. By confocal microscopy analysis we found an increased number of cells with supernumerary centrosomes. Live imaging showed a significant increase in mitosis abnormalities, including multipolar spindle, chromosome laggards, micronuclei and death of progeny after cell division. FISH analysis for chromosomes 12 and 17 showed increased frequency of aneuploidy, such as monosomy, trisomy and polyploidy. Our study reinforces the link between ZIKV and abnormalities in the developing human brain, including microcephaly.

1 May 2021 in Emerging Infectious Diseases
Verified
Journal Article
Closed access
CNCarolina K. V. Nonaka
Carolina K. V. Nonaka
MFMarília Miranda Franco
Marília Miranda Franco
TGTiago Gräf
Tiago Gräf
CBCamila Araújo de Lorenzo Barcia
Camila Araújo de Lorenzo Barcia
RMRenata Naves de Ávila Mendonça
Renata Naves de Ávila Mendonça
BSBRUNO SOUZA
BRUNO SOUZA
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil

Verified
Journal Article
Open access
PDF file
Alex Cleber Improta CariaAlex Cleber Improta Caria
Alex Cleber Improta Caria
CNCarolina Kymie Vasques Nonaka
Carolina Kymie Vasques Nonaka
CPCiro Silveira Pereira
Ciro Silveira Pereira
Milena SoaresMilena Soares
Milena Soares
SMSimone Garcia Macambira
Simone Garcia Macambira
BSBRUNO SOUZA
BRUNO SOUZA
MicroRNAs are small non-coding RNAs that regulate gene expression post-transcriptionally. They are involved in the regulation of physiological processes, such as adaptation to physical exercise, and also in disease settings, such as systemic arterial hypertension (SAH), type 2 diabetes mellitus (T2D), and obesity. In SAH, microRNAs play a significant role in the regulation of key signaling pathways that lead to the hyperactivation of the renin-angiotensin-aldosterone system, endothelial dysfunction, inflammation, proliferation, and phenotypic change in smooth muscle cells, and the hyperactivation of the sympathetic nervous system. MicroRNAs are also involved in the regulation of insulin signaling and blood glucose levels in T2D, and participate in lipid metabolism, adipogenesis, and adipocyte differentiation in obesity, with specific microRNA signatures involved in the pathogenesis of each disease. Many studies report the benefits promoted by exercise training in cardiovascular diseases by reducing blood pressure, glucose levels, and improving insulin signaling and lipid metabolism. The molecular mechanisms involved, however, remain poorly understood, especially regarding the participation of microRNAs in these processes. This review aimed to highlight microRNAs already known to be associated with SAH, T2D, and obesity, as well as their possible regulation by exercise training.

1 October 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
CNCarolina Kymie Vasques Nonaka
Carolina Kymie Vasques Nonaka
TGTiago Gräf
Tiago Gräf
CBCamila Araújo de Lorenzo Barcia
Camila Araújo de Lorenzo Barcia
VCVanessa Ferreira Costa
Vanessa Ferreira Costa
JOJanderson Lopes de Oliveira
Janderson Lopes de Oliveira
BSBRUNO SOUZA
BRUNO SOUZA
To evaluate changes in COVID-19 patients' characteristics occurring after the emergence of the SARS-CoV-2 variant of concern (VOC) P.1 (Gamma) by comparing the clinical, demographic and laboratory profile of patients hospitalized during the first (May-July 2020) and second (December 2020 - February 2021) pandemic waves. Data was collected from records of COVID-19 patients (n=4164) admitted to a single hospital in Salvador, Northeast Brazil. SARS-CoV-2 genome sequencing was performed in nasopharyngeal swab samples from 12 patients with age < 60 years-old admitted to the intensive care units (ICU) in February 2021. From June 2020 to February 2021, the median age of patients admitted in the ICU decreased from 66 to 58 years (p<0.05), accompanied by an increased proportion of patients without comorbidities (15.32% vs 32.20%, p<0.0001). A significant reduction in the Ct values of SARS-CoV-2 RT-PCR tests was observed in the second wave (p<0.0001). Sequencing analysis detected lineage Gamma in all 12 ICU patients sampled in February 2021. Our results demonstrated an increased proportion of younger adults without comorbidities with severe disease during the second COVID-19 wave, shortly after the confirmation of local Gamma circulation.

Verified
Journal Article
Open access
PDF file
RSRicardo De Sousa
Ricardo De Sousa
Alex Cleber Improta CariaAlex Cleber Improta Caria
Alex Cleber Improta Caria
BSBRUNO SOUZA
BRUNO SOUZA
Type 2 diabetes mellitus (T2DM) is a metabolic disorder associated with insulin resistance and hyperglycemia. Chronic exposure to a T2DM microenvironment with hyperglycemia, hyperinsulinemia, oxidative stress and increased levels of proinflammatory mediators, has negative consequences to the cardiovascular system and mental health. Therefore, atherosclerotic cardiovascular diseases (CVD) and mental health issues have been strongly associated with T2DM. Lifestyle modifications, including physical exercise training, are necessary to prevent T2DM development and its associated complications. It is widely known that the regular practice of exercise provides several physiological benefits to subjects with T2DM, such as managing glycemic and blood pressure levels. Different types of exercise, from aerobic to resistance training, are effective to improve mental health and cognitive function in T2DM. Irisin is a myokine produced in response to exercise, which has been pointed as a relevant mechanism of action to explain the benefits of exercise on cardiovascular and mental health in T2DM patients. Here, we review emerging clinical and experimental evidence about exercise-linked irisin consequences to cardiovascular and mental health in T2DM.

21 May 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
KAKyan James Allahdadi
Kyan James Allahdadi
TSThaís Alves de Santana
Thaís Alves de Santana
GSGirlaine Café Santos
Girlaine Café Santos
CACarine Machado Azevedo
Carine Machado Azevedo
RMRoberta Alves Mota
Roberta Alves Mota
Milena SoaresMilena Soares
Milena Soares
Survival and therapeutic actions of bone marrow-derived mesenchymal stem cells (BMMSCs) can be limited by the hostile microenvironment present during acute spinal cord injury (SCI). Here, we investigated whether BMMSCs overexpressing insulin-like growth factor 1 (IGF-1), a cytokine involved in neural development and injury repair, improved the therapeutic effects of BMMSCs in SCI. Using a SCI contusion model in C57Bl/6 mice, we transplanted IGF-1 overexpressing or wild-type BMMSCs into the lesion site following SCI and evaluated cell survival, proliferation, immunomodulation, oxidative stress, myelination, and functional outcomes. BMMSC-IGF1 transplantation was associated with increased cell survival and recruitment of endogenous neural progenitor cells compared to BMMSC- or saline-treated controls. Modulation of gene expression of pro- and anti-inflammatory mediators was observed after BMMSC-IGF1 and compared to saline- and BMMSC-treated mice. Treatment with BMMSC-IGF1 restored spinal cord redox homeostasis by upregulating antioxidant defense genes. BMMSC-IGF1 protected against SCI-induced myelin loss, showing more compact myelin 28 days after SCI. Functional analyses demonstrated significant gains in BMS score and gait analysis in BMMSC-IGF1, compared to BMMSC or saline treatment. Overexpression of IGF-1 in BMMSC resulted in increased cell survival, immunomodulation, myelination, and functional improvements, suggesting that IGF-1 facilitates the regenerative actions of BMMSC in acute SCI.